Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ameer Hassan

Vascular Neurology Harlingen, TX Doctor of Osteopathy

NPI 1790941052 CMS profile 126971

2222 Vela Dr, Harlingen, TX 78550

Open in the dashboard

General payments

$1,024,492

920 records reported · program years 2019–2025

Research payments

$66

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$3,098,525

8 holdings reported · through program year 2025

Research they led as principal investigator

$499,293 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ameer Hassan of Harlingen, TX is reported in the CMS Open Payments database as having received $1,024,492 across 920 general payments and $66 in research payments paid to them. Separately, studies naming them as principal investigator received $499,293 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $3,098,525 across 8 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $192,754 199
2024 General $140,770 99
2023 General $99,297 83
2022 General $111,923 124
2021 General $171,426 170
2020 General $137,172 111
2019 General $171,150 134
2019 Research $66 1
2025 Ownership $1,373,776 2
2024 Ownership $1,263,776 3
2022 Ownership $303,908 2
2021 Ownership $157,065 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ameer Hassan
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Ameer Hassan were reported at $192,754. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Ameer Hassan Vascular Neurology median Middle half National median
2019 $171,150 $263 $102–$1,640 $163
2020 $137,172 $153 $45–$1,000 $114
2021 $171,426 $261 $100–$1,355 $132
2022 $111,923 $242 $87–$1,273 $149
2023 $99,297 $322 $97–$1,266 $160
2024 $140,770 $247 $70–$1,053 $164
2025 $192,754 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $295,965 310 payments
  2. Stryker Corporation $113,182 119 payments
  3. Medtronic USA, Inc. $81,905 89 payments
  4. Ge Healthcare $77,261 23 payments
  5. Penumbra, Inc. $66,270 78 payments
  6. Genentech USA, Inc. $60,548 37 payments
  7. Rapid Medical LTD $59,881 11 payments
  8. MicroVention, Inc. $48,919 53 payments
  9. Asahi Intecc USA, Inc. $39,566 10 payments
  10. Perfuze Limited $37,278 6 payments
  11. Other $143,717 184 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $411,929 106 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $343,424 92 payments
  3. Travel and Lodging $198,561 279 payments
  4. Honoraria $39,200 3 payments
  5. Food and Beverage $31,378 440 payments
Products named General payments · program years 2019–2025
  1. Pipeline Flow Diversion $77,980 149 payments
  2. COMANECI 17 $50,810 10 payments
  3. Solitaire $45,149 18 payments
  4. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $34,289 5 payments
  5. Penumbra System $31,990 32 payments
  6. PERIPHERAL VASCULAR $31,985 13 payments
  7. SURPASS EVOLVE $29,431 47 payments
  8. Pipeline Flow Diversion $28,587 26 payments
  9. EMBOGUARD $22,324 10 payments
  10. ASAHI Neurovascular Guide Wire $20,000 2 payments
  11. Other $421,932 469 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. MicroVention, Inc. $66 1 payment

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$60,933

Medicare's payments for the services billed

Medicare patients

42

Average age 74

Services billed

367

21 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 64%
Arthritis 62%
Ischemic heart disease 55%
Chronic kidney disease 40%
Heart failure 26%
COPD 26%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TNKase
$66 — —
Activase
$23 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

921 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record